144 related articles for article (PubMed ID: 22764879)
1. Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection.
Petta S; Macaluso FS; Cammà C; Marco VD; Cabibi D; Craxì A
Liver Int; 2012 Oct; 32(9):1443-50. PubMed ID: 22764879
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
[TBL] [Abstract][Full Text] [Related]
3. High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.
Petta S; Handberg A; Marchesini G; Cammà C; Di Marco V; Cabibi D; Macaluso FS; Craxì A
J Viral Hepat; 2013 Mar; 20(3):174-82. PubMed ID: 23383656
[TBL] [Abstract][Full Text] [Related]
4. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
Petta S; Cammà C; Di Marco V; Alessi N; Barbaria F; Cabibi D; Caldarella R; Ciminnisi S; Licata A; Massenti MF; Mazzola A; Tarantino G; Marchesini G; Craxì A
Hepatology; 2008 Jul; 48(1):28-37. PubMed ID: 18506842
[TBL] [Abstract][Full Text] [Related]
5. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
8. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
[TBL] [Abstract][Full Text] [Related]
9. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
[TBL] [Abstract][Full Text] [Related]
10. Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
Pellicano R; Puglisi G; Ciancio A; Balzola F; Saracco G; Ciccone G; Baldi I; Abate ML; Smedile A; Rizzetto M
J Med Virol; 2008 Apr; 80(4):628-31. PubMed ID: 18297716
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
12. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
Hézode C; Zafrani ES; Roudot-Thoraval F; Costentin C; Hessami A; Bouvier-Alias M; Medkour F; Pawlostky JM; Lotersztajn S; Mallat A
Gastroenterology; 2008 Feb; 134(2):432-9. PubMed ID: 18242211
[TBL] [Abstract][Full Text] [Related]
13. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C.
Romero-Gómez M; Castellano-Megias VM; Grande L; Irles JA; Cruz M; Nogales MC; Alcón JC; Robles A
Am J Gastroenterol; 2003 May; 98(5):1135-41. PubMed ID: 12809839
[TBL] [Abstract][Full Text] [Related]
15. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.
Aksu HS; Kurtaran B; Onlen Y; Namiduru M; Inkaya AC; Kandemir O; Doran F; Evirgen O; Alpay Y; Tekin SK; Kurekci Y; Unlu B; Midikli D; Taşova Y; Ozdener F; Erdogan S
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1393-9. PubMed ID: 23114743
[TBL] [Abstract][Full Text] [Related]
16. Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.
Maylin S; Laouénan C; Martinot-Peignoux M; Panhard X; Lapalus M; Nicolas-Chanoine MH; Bedossa P; Asselah T; Marcellin P
J Clin Virol; 2012 Jan; 53(1):43-7. PubMed ID: 22099210
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
19. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.
Kukla M; Berdowska A; Stygar D; Gabriel A; Mazur W; Łogiewa-Bazger B; Sobala-Szczygieł B; Bułdak RJ; Rokitka M; Zajęcki W; Kępa L; Sawczyn T; Zwirska-Korczala K
Scand J Gastroenterol; 2012 Sep; 47(8-9):1037-47. PubMed ID: 22670657
[TBL] [Abstract][Full Text] [Related]
20. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
